Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Sore Antiviral Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Smear
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cold Sore Antiviral Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Child
1.3.3 Aldult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold Sore Antiviral Drug Market Perspective (2018-2033)
2.2 Cold Sore Antiviral Drug Growth Trends by Region
2.2.1 Global Cold Sore Antiviral Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cold Sore Antiviral Drug Historic Market Size by Region (2018-2023)
2.2.3 Cold Sore Antiviral Drug Forecasted Market Size by Region (2024-2033)
2.3 Cold Sore Antiviral Drug Market Dynamics
2.3.1 Cold Sore Antiviral Drug Industry Trends
2.3.2 Cold Sore Antiviral Drug Market Drivers
2.3.3 Cold Sore Antiviral Drug Market Challenges
2.3.4 Cold Sore Antiviral Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Sore Antiviral Drug Players by Revenue
3.1.1 Global Top Cold Sore Antiviral Drug Players by Revenue (2018-2023)
3.1.2 Global Cold Sore Antiviral Drug Revenue Market Share by Players (2018-2023)
3.2 Global Cold Sore Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold Sore Antiviral Drug Revenue
3.4 Global Cold Sore Antiviral Drug Market Concentration Ratio
3.4.1 Global Cold Sore Antiviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Sore Antiviral Drug Revenue in 2022
3.5 Cold Sore Antiviral Drug Key Players Head office and Area Served
3.6 Key Players Cold Sore Antiviral Drug Product Solution and Service
3.7 Date of Enter into Cold Sore Antiviral Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Sore Antiviral Drug Breakdown Data by Type
4.1 Global Cold Sore Antiviral Drug Historic Market Size by Type (2018-2023)
4.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2024-2033)
5 Cold Sore Antiviral Drug Breakdown Data by Application
5.1 Global Cold Sore Antiviral Drug Historic Market Size by Application (2018-2023)
5.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cold Sore Antiviral Drug Market Size (2018-2033)
6.2 North America Cold Sore Antiviral Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cold Sore Antiviral Drug Market Size by Country (2018-2023)
6.4 North America Cold Sore Antiviral Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold Sore Antiviral Drug Market Size (2018-2033)
7.2 Europe Cold Sore Antiviral Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cold Sore Antiviral Drug Market Size by Country (2018-2023)
7.4 Europe Cold Sore Antiviral Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Sore Antiviral Drug Market Size (2018-2033)
8.2 Asia-Pacific Cold Sore Antiviral Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold Sore Antiviral Drug Market Size (2018-2033)
9.2 Latin America Cold Sore Antiviral Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cold Sore Antiviral Drug Market Size by Country (2018-2023)
9.4 Latin America Cold Sore Antiviral Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Sore Antiviral Drug Market Size (2018-2033)
10.2 Middle East & Africa Cold Sore Antiviral Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Ortho Dermatologics
11.2.1 Ortho Dermatologics Company Detail
11.2.2 Ortho Dermatologics Business Overview
11.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Introduction
11.2.4 Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.2.5 Ortho Dermatologics Recent Development
11.3 Foundation Consumer Healthcare
11.3.1 Foundation Consumer Healthcare Company Detail
11.3.2 Foundation Consumer Healthcare Business Overview
11.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Introduction
11.3.4 Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.3.5 Foundation Consumer Healthcare Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold Sore Antiviral Drug Introduction
11.4.4 Novartis Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.5.4 Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Amneal Pharmaceuticals LLC
11.6.1 Amneal Pharmaceuticals LLC Company Detail
11.6.2 Amneal Pharmaceuticals LLC Business Overview
11.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Introduction
11.6.4 Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.6.5 Amneal Pharmaceuticals LLC Recent Development
11.7 AiCuris
11.7.1 AiCuris Company Detail
11.7.2 AiCuris Business Overview
11.7.3 AiCuris Cold Sore Antiviral Drug Introduction
11.7.4 AiCuris Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.7.5 AiCuris Recent Development
11.8 Apotex
11.8.1 Apotex Company Detail
11.8.2 Apotex Business Overview
11.8.3 Apotex Cold Sore Antiviral Drug Introduction
11.8.4 Apotex Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.8.5 Apotex Recent Development
11.9 Aurobindo Pharma USA, Inc.
11.9.1 Aurobindo Pharma USA, Inc. Company Detail
11.9.2 Aurobindo Pharma USA, Inc. Business Overview
11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Introduction
11.9.4 Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.9.5 Aurobindo Pharma USA, Inc. Recent Development
11.10 Cipla
11.10.1 Cipla Company Detail
11.10.2 Cipla Business Overview
11.10.3 Cipla Cold Sore Antiviral Drug Introduction
11.10.4 Cipla Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.10.5 Cipla Recent Development
11.11 Glenmark Pharmaceuticals, Inc.
11.11.1 Glenmark Pharmaceuticals, Inc. Company Detail
11.11.2 Glenmark Pharmaceuticals, Inc. Business Overview
11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Introduction
11.11.4 Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.11.5 Glenmark Pharmaceuticals, Inc. Recent Development
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Detail
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.12.5 Hikma Pharmaceuticals Recent Development
11.13 HRA Pharma
11.13.1 HRA Pharma Company Detail
11.13.2 HRA Pharma Business Overview
11.13.3 HRA Pharma Cold Sore Antiviral Drug Introduction
11.13.4 HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.13.5 HRA Pharma Recent Development
11.14 Hetero Healthcare Ltd
11.14.1 Hetero Healthcare Ltd Company Detail
11.14.2 Hetero Healthcare Ltd Business Overview
11.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Introduction
11.14.4 Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.14.5 Hetero Healthcare Ltd Recent Development
11.15 Jubilant Cadista
11.15.1 Jubilant Cadista Company Detail
11.15.2 Jubilant Cadista Business Overview
11.15.3 Jubilant Cadista Cold Sore Antiviral Drug Introduction
11.15.4 Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.15.5 Jubilant Cadista Recent Development
11.16 Merix Pharmaceutical Corp
11.16.1 Merix Pharmaceutical Corp Company Detail
11.16.2 Merix Pharmaceutical Corp Business Overview
11.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Introduction
11.16.4 Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.16.5 Merix Pharmaceutical Corp Recent Development
11.17 Sun Pharmaceutical Industries Ltd.
11.17.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.17.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Introduction
11.17.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.17.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.18 Viatris
11.18.1 Viatris Company Detail
11.18.2 Viatris Business Overview
11.18.3 Viatris Cold Sore Antiviral Drug Introduction
11.18.4 Viatris Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.18.5 Viatris Recent Development
11.19 Wockhardt
11.19.1 Wockhardt Company Detail
11.19.2 Wockhardt Business Overview
11.19.3 Wockhardt Cold Sore Antiviral Drug Introduction
11.19.4 Wockhardt Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.19.5 Wockhardt Recent Development
11.20 Zydus Pharmaceuticals
11.20.1 Zydus Pharmaceuticals Company Detail
11.20.2 Zydus Pharmaceuticals Business Overview
11.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.20.4 Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2018-2023)
11.20.5 Zydus Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cold Sore Antiviral Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Smear
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Cold Sore Antiviral Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cold Sore Antiviral Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cold Sore Antiviral Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cold Sore Antiviral Drug Market Share by Region (2018-2023)
Table 9. Global Cold Sore Antiviral Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Cold Sore Antiviral Drug Market Share by Region (2024-2033)
Table 11. Cold Sore Antiviral Drug Market Trends
Table 12. Cold Sore Antiviral Drug Market Drivers
Table 13. Cold Sore Antiviral Drug Market Challenges
Table 14. Cold Sore Antiviral Drug Market Restraints
Table 15. Global Cold Sore Antiviral Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cold Sore Antiviral Drug Market Share by Players (2018-2023)
Table 17. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2022)
Table 18. Ranking of Global Top Cold Sore Antiviral Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cold Sore Antiviral Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cold Sore Antiviral Drug Product Solution and Service
Table 22. Date of Enter into Cold Sore Antiviral Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cold Sore Antiviral Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2024-2033)
Table 28. Global Cold Sore Antiviral Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2024-2033)
Table 32. North America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Cold Sore Antiviral Drug Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cold Sore Antiviral Drug Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Cold Sore Antiviral Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cold Sore Antiviral Drug Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Cold Sore Antiviral Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Cold Sore Antiviral Drug Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cold Sore Antiviral Drug Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2024-2033) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Cold Sore Antiviral Drug Product
Table 50. GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Ortho Dermatologics Company Detail
Table 53. Ortho Dermatologics Business Overview
Table 54. Ortho Dermatologics Cold Sore Antiviral Drug Product
Table 55. Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 56. Ortho Dermatologics Recent Development
Table 57. Foundation Consumer Healthcare Company Detail
Table 58. Foundation Consumer Healthcare Business Overview
Table 59. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product
Table 60. Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 61. Foundation Consumer Healthcare Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Cold Sore Antiviral Drug Product
Table 65. Novartis Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Teva Pharmaceuticals Company Detail
Table 68. Teva Pharmaceuticals Business Overview
Table 69. Teva Pharmaceuticals Cold Sore Antiviral Drug Product
Table 70. Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 71. Teva Pharmaceuticals Recent Development
Table 72. Amneal Pharmaceuticals LLC Company Detail
Table 73. Amneal Pharmaceuticals LLC Business Overview
Table 74. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product
Table 75. Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 76. Amneal Pharmaceuticals LLC Recent Development
Table 77. AiCuris Company Detail
Table 78. AiCuris Business Overview
Table 79. AiCuris Cold Sore Antiviral Drug Product
Table 80. AiCuris Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 81. AiCuris Recent Development
Table 82. Apotex Company Detail
Table 83. Apotex Business Overview
Table 84. Apotex Cold Sore Antiviral Drug Product
Table 85. Apotex Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 86. Apotex Recent Development
Table 87. Aurobindo Pharma USA, Inc. Company Detail
Table 88. Aurobindo Pharma USA, Inc. Business Overview
Table 89. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product
Table 90. Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 91. Aurobindo Pharma USA, Inc. Recent Development
Table 92. Cipla Company Detail
Table 93. Cipla Business Overview
Table 94. Cipla Cold Sore Antiviral Drug Product
Table 95. Cipla Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 96. Cipla Recent Development
Table 97. Glenmark Pharmaceuticals, Inc. Company Detail
Table 98. Glenmark Pharmaceuticals, Inc. Business Overview
Table 99. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product
Table 100. Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 101. Glenmark Pharmaceuticals, Inc. Recent Development
Table 102. Hikma Pharmaceuticals Company Detail
Table 103. Hikma Pharmaceuticals Business Overview
Table 104. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product
Table 105. Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 106. Hikma Pharmaceuticals Recent Development
Table 107. HRA Pharma Company Detail
Table 108. HRA Pharma Business Overview
Table 109. HRA Pharma Cold Sore Antiviral Drug Product
Table 110. HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 111. HRA Pharma Recent Development
Table 112. Hetero Healthcare Ltd Company Detail
Table 113. Hetero Healthcare Ltd Business Overview
Table 114. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product
Table 115. Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 116. Hetero Healthcare Ltd Recent Development
Table 117. Jubilant Cadista Company Detail
Table 118. Jubilant Cadista Business Overview
Table 119. Jubilant Cadista Cold Sore Antiviral Drug Product
Table 120. Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 121. Jubilant Cadista Recent Development
Table 122. Merix Pharmaceutical Corp Company Detail
Table 123. Merix Pharmaceutical Corp Business Overview
Table 124. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product
Table 125. Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 126. Merix Pharmaceutical Corp Recent Development
Table 127. Sun Pharmaceutical Industries Ltd. Company Detail
Table 128. Sun Pharmaceutical Industries Ltd. Business Overview
Table 129. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product
Table 130. Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 131. Sun Pharmaceutical Industries Ltd. Recent Development
Table 132. Viatris Company Detail
Table 133. Viatris Business Overview
Table 134. Viatris Cold Sore Antiviral Drug Product
Table 135. Viatris Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 136. Viatris Recent Development
Table 137. Wockhardt Company Detail
Table 138. Wockhardt Business Overview
Table 139. Wockhardt Cold Sore Antiviral Drug Product
Table 140. Wockhardt Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 141. Wockhardt Recent Development
Table 142. Zydus Pharmaceuticals Company Detail
Table 143. Zydus Pharmaceuticals Business Overview
Table 144. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product
Table 145. Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2018-2023) & (US$ Million)
Table 146. Zydus Pharmaceuticals Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cold Sore Antiviral Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cold Sore Antiviral Drug Market Share by Type: 2022 VS 2033
Figure 3. Smear Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Cold Sore Antiviral Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Cold Sore Antiviral Drug Market Share by Application: 2022 VS 2033
Figure 8. Child Case Studies
Figure 9. Aldult Case Studies
Figure 10. Cold Sore Antiviral Drug Report Years Considered
Figure 11. Global Cold Sore Antiviral Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Cold Sore Antiviral Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Cold Sore Antiviral Drug Market Share by Region: 2022 VS 2033
Figure 14. Global Cold Sore Antiviral Drug Market Share by Players in 2022
Figure 15. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cold Sore Antiviral Drug Revenue in 2022
Figure 17. North America Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Cold Sore Antiviral Drug Market Share by Country (2018-2033)
Figure 19. United States Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Cold Sore Antiviral Drug Market Share by Country (2018-2033)
Figure 23. Germany Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Cold Sore Antiviral Drug Market Share by Region (2018-2033)
Figure 31. China Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Cold Sore Antiviral Drug Market Share by Country (2018-2033)
Figure 39. Mexico Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Cold Sore Antiviral Drug Market Share by Country (2018-2033)
Figure 43. Turkey Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Cold Sore Antiviral Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 46. Ortho Dermatologics Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 47. Foundation Consumer Healthcare Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 50. Amneal Pharmaceuticals LLC Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 51. AiCuris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 52. Apotex Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 53. Aurobindo Pharma USA, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 54. Cipla Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 55. Glenmark Pharmaceuticals, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 56. Hikma Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 57. HRA Pharma Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 58. Hetero Healthcare Ltd Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 59. Jubilant Cadista Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 60. Merix Pharmaceutical Corp Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 61. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 62. Viatris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 63. Wockhardt Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 64. Zydus Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed